![](/img/cover-not-exists.png)
Alirocumab Versus Ezetimibe Over 104 Weeks In Individuals With Hypercholesterolemia And High Cardiovascular Risk: Final Results From ODYSSEY COMBO II
El Shahawy, Mahfouz, Cannon, Christopher, Blom, Dirk, McKenney, James, Cariou, Bertrand, Lecorps, Guillaume, Pordy, Robert, Chaudhari, Umesh, Colhoun, HelenVolume:
10
Language:
english
Journal:
Journal of Clinical Lipidology
DOI:
10.1016/j.jacl.2016.03.095
Date:
May, 2016
File:
PDF, 356 KB
english, 2016